Literature DB >> 24480307

A mutation interfering with 5-lipoxygenase domain interaction leads to increased enzyme activity.

Marija Rakonjac Ryge1, Michiharu Tanabe2, Patrick Provost3, Bengt Persson4, Xinsheng Chen5, Colin D Funk6, Agnes Rinaldo-Matthis1, Bettina Hofmann7, Dieter Steinhilber7, Takashi Watanabe8, Bengt Samuelsson1, Olof Rådmark9.   

Abstract

5-Lipoxygenase (5-LOX) catalyzes two steps in conversion of arachidonic acid to proinflammatory leukotrienes. Lipoxygenases, including human 5-LOX, consist of an N-terminal C2-like β-sandwich and a catalytic domain. We expressed the 5-LOX domains separately, these were found to interact in the yeast two-hybrid system. The 5-LOX structure suggested association between Arg(101) in the β-sandwich and Asp(166) in the catalytic domain, due to electrostatic interaction as well as hydrogen bonds. Indeed, mutagenic replacements of these residues led to loss of two-hybrid interaction. Interestingly, when Arg(101) was mutated to Asp in intact 5-LOX, enzyme activity was increased. Thus, higher initial velocity of the reaction (vinit) and increased final amount of products were monitored for 5-LOX-R101D, at several different assay conditions. In the 5-LOX crystal structure, helix α2 and adjacent loops (including Asp(166)) of the 5-LOX catalytic domain has been proposed to form a flexible lid controlling access to the active site, and lid movement would be determined by bonding of lid residues to the C2-like β-sandwich. The more efficient catalysis following disruption of the R101-D166 ionic association supports the concept of such a flexible lid in human 5-LOX.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arachidonic acid; Domain interaction; Eicosanoid; Leukotriene; Two-hybrid system

Mesh:

Substances:

Year:  2014        PMID: 24480307     DOI: 10.1016/j.abb.2014.01.017

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Identification of the Substrate Access Portal of 5-Lipoxygenase.

Authors:  Sunayana Mitra; Sue G Bartlett; Marcia E Newcomer
Journal:  Biochemistry       Date:  2015-10-08       Impact factor: 3.162

2.  Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products.

Authors:  Nathaniel C Gilbert; Jana Gerstmeier; Erin E Schexnaydre; Friedemann Börner; Ulrike Garscha; David B Neau; Oliver Werz; Marcia E Newcomer
Journal:  Nat Chem Biol       Date:  2020-05-11       Impact factor: 15.040

3.  A 5‑lipoxygenase-specific sequence motif impedes enzyme activity and confers dependence on a partner protein.

Authors:  Erin E Schexnaydre; Jana Gerstmeier; Ulrike Garscha; Paul M Jordan; Oliver Werz; Marcia E Newcomer
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-10-03       Impact factor: 4.698

4.  Identification and Characterization of a New Protein Isoform of Human 5-Lipoxygenase.

Authors:  Ann-Kathrin Häfner; Kim Beilstein; Philipp Graab; Ann-Katrin Ball; Meike J Saul; Bettina Hofmann; Dieter Steinhilber
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

5.  Structural Dynamics of 15-Lipoxygenase-2 via Hydrogen-Deuterium Exchange.

Authors:  Kristin D Droege; Mary E Keithly; Charles R Sanders; Richard N Armstrong; Matthew K Thompson
Journal:  Biochemistry       Date:  2017-09-07       Impact factor: 3.162

6.  Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor.

Authors:  Tiago Rodrigues; Markus Werner; Jakob Roth; Eduardo H G da Cruz; Marta C Marques; Padma Akkapeddi; Susana A Lobo; Andreas Koeberle; Francisco Corzana; Eufrânio N da Silva Júnior; Oliver Werz; Gonçalo J L Bernardes
Journal:  Chem Sci       Date:  2018-07-17       Impact factor: 9.825

Review 7.  Fatty Acid Allosteric Regulation of C-H Activation in Plant and Animal Lipoxygenases.

Authors:  Adam R Offenbacher; Theodore R Holman
Journal:  Molecules       Date:  2020-07-24       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.